Schizophrenia.com, Indepth Schizophrenia Information and Support. Schizophrenia. Schizophrenia - Schizophrenia - NCBI Bookshelf. Brain Training and Schizophrenia: How to Boost Social Cognitive Skills. By: Dr. Pascale Michelon Individuals suffering from schizophrenia show social cognitive deficits, that is difficulties in perceiving and understanding the social world. Research shows that schizophrenia is accompanied by social cognition problems such as problems identifying facial expressions, understanding and responding to social cues (e.g., body language), understanding that others have different mental states and thoughts than oneself (also called Theory of mind).
These deficits are usually persistent over time and resist pharmacological treatment. Interestingly, social cognition may be trainable. Produce a moderate to large improvement in the recognition of facial emotionsproduce a smaller improvement in Theory of minddo not improve social perception (such as understanding voice intonation or body language) Related post: Schizophrenia Research is Leading the Way in Cognitive Remediation. American Journal of Psychiatry | A Functional Magnetic Resonance Imaging Study of Social Cognition in Schizophrenia During an Acute Episode and After Recovery.
Mental Health America: Mental Health Legislative Advocacy Priorities. Founded in 1909, Mental Health America (MHA) – with more than 200 affiliates across the United States – is the nation’s leading community-based nonprofit dedicated to addressing the needs of those living with mental illness and to promoting the overall mental health of all Americans. Mental health conditions should be treated long before crisis. When we think about cancer, heart disease, or diabetes, we don’t wait years to treat them. We start before Stage 4— we try to prevent illness, address symptoms early, and develop a plan for treatment. Left untreated, people slowly lose their ability to live the life they and their families imagined – as healthy, successful, and contributing members of their community. MHA collaborates with scientists, practitioners, policy experts, advocates, and other community leaders to design policy recommendations that promote:
Infections Linked to Schizophrenia. By Rick Nauert PhD Senior News Editor Reviewed by John M. Grohol, Psy.D. on November 20, 2009 Swedish researchers have developed a technique that analyzes inflammatory substances in cerebrospinal fluid — the liquid that surrounds the brain and spinal cord. Using this method they discovered patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Although the cause of schizophrenia is unknown, this new finding may give support to the theory that infections early in life might increase the risk of developing schizophrenia.
Furthermore, the discovery improves the potential to treat schizophrenia with drugs that affect the immune system. The new analysis technique assesses inflammatory substances in the spinal fluid of patients with schizophrenia, instead of, as in previous studies, in the blood. “This suggests that the brain’s immune defense system is activated in schizophrenia,” says Professor Göran Engberg, who led the study. Prevention and Recovery in Early Psychosis. All About Schizophrenia and Psychosis. Schizophrenia Information & Treatment Introduction Throughout recorded history, the disorder we now know as schizophrenia has been a source of bewilderment.
Those suffering from the illness once were thought to be possessed by demons and were feared, tormented, exiled or locked up forever. In spite of advances in the understanding of its causes, course and treatment, schizophrenia continues to confound both health professionals and the public. It is easier for the average person to cope with the idea of cancer than it is to understand the odd behavior, hallucinations or strange ideas of the person with schizophrenia.
As with many mental disorders, the causes of schizophrenia are poorly understood. Friends and family commonly are shocked, afraid or angry when they learn of the diagnosis. Expectations become more realistic as schizophrenia is better understood as a disorder that requires ongoing -- often lifetime -- treatment. Delusions & Hallucinations Are Common in Schizophrenia. Types of Schizophrenia. The kinds of symptoms that are utilized to make a diagnosis of schizophrenia differ between affected people and may change from one year to the next within the same person as the disease progresses. Different subtypes of schizophrenia are defined according to the most significant and predominant characteristics present in each person at each point in time. The result is that one person may be diagnosed with different subtypes over the course of his illness. Schizophrenia: Paranoid Subtype The defining feature of the paranoid subtype (also known as paranoid schizophrenia) is the presence of auditory hallucinations or prominent delusional thoughts about persecution or conspiracy.
However, people with this subtype may be more functional in their ability to work and engage in relationships than people with other subtypes of schizophrenia. Paranoid schizophrenia is the most common subtype. There is a broad spectrum to the nature and severity of symptoms that may be present at any one time. New Genetic Link for Schizophrenia. By Rick Nauert PhD Senior News Editor Reviewed by John M. Grohol, Psy.D. on March 20, 2007 Researchers have uncovered evidence of a new gene that appears to increase the risk of developing schizophrenia, a disorder characterized by distorted thinking, hallucinations and a reduced ability to feel normal emotions. The scientists utilized a cutting-edge technology called whole genome association (WGA) to search the entire human genome in 178 patients with schizophrenia and 144 healthy individuals. WGA technology was used to examine over 500,000 genetic markers in each individual, the largest number of such markers examined to date, and the first published study to utilize WGA technology in a psychiatric illness.
Previous studies have been much more limited in scope, often incorporating less than 10 markers. The study results are scheduled to be published online in Molecular Psychiatry, which can be accessed at.